GB1002278A - Cytidine derivatives and the preparation thereof - Google Patents

Cytidine derivatives and the preparation thereof

Info

Publication number
GB1002278A
GB1002278A GB5220264A GB5220264A GB1002278A GB 1002278 A GB1002278 A GB 1002278A GB 5220264 A GB5220264 A GB 5220264A GB 5220264 A GB5220264 A GB 5220264A GB 1002278 A GB1002278 A GB 1002278A
Authority
GB
United Kingdom
Prior art keywords
preparation
toluoyl
cytidine
cytidine derivatives
deoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5220264A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1002278A publication Critical patent/GB1002278A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises 4-(N-p-toluoyl)-21-deoxy-5-fluoro-cytidine and its alpha anomer, and a process for their preparation comprises mixing 4 - (N - p - toluoyl) - 31, 51 - di - (O - p -toluoyl) - 21 - deoxy - 5 - fluoro - cytidine or its alpha anomer with an alkali metal alkoxide, e.g. sodium methoxide, or with alcoholic ammonia at room temperature or below.
GB5220264A 1962-05-01 1963-05-01 Cytidine derivatives and the preparation thereof Expired GB1002278A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19143862A 1962-05-01 1962-05-01

Publications (1)

Publication Number Publication Date
GB1002278A true GB1002278A (en) 1965-08-25

Family

ID=22705512

Family Applications (3)

Application Number Title Priority Date Filing Date
GB5220164A Expired GB989456A (en) 1962-05-01 1963-05-01 Cytosine derivatives and the preparation thereof
GB1706363A Expired GB989455A (en) 1962-05-01 1963-05-01 Cytosine derivatives and the manufacture thereof
GB5220264A Expired GB1002278A (en) 1962-05-01 1963-05-01 Cytidine derivatives and the preparation thereof

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GB5220164A Expired GB989456A (en) 1962-05-01 1963-05-01 Cytosine derivatives and the preparation thereof
GB1706363A Expired GB989455A (en) 1962-05-01 1963-05-01 Cytosine derivatives and the manufacture thereof

Country Status (6)

Country Link
BR (1) BR6348745D0 (en)
CH (1) CH421973A (en)
DK (1) DK115916B (en)
ES (1) ES287587A1 (en)
FR (1) FR1514917A (en)
GB (3) GB989456A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA106889C2 (en) * 2009-08-07 2014-10-27 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі N1-ACYL-5-FLORPYRIMIDINONE DERIVATIVES
WO2014105844A1 (en) 2012-12-28 2014-07-03 Dow Agrosciences Llc N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1 (2h)-carboxylate derivatives
UA117123C2 (en) 2012-12-28 2018-06-25 Адама Махтешім Лтд. 1-(substituted-benzoyl)-5-fluoro-4-imino-3-methyl-3,4-dihydropyrimidin-2(1h)-one derivatives
KR20150100869A (en) 2012-12-28 2015-09-02 다우 아그로사이언시즈 엘엘씨 N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1 (2h)-carboxamides derivatives
WO2014105845A1 (en) 2012-12-31 2014-07-03 Dow Agrosciences Llc 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1h)-one derivatives as fungicides

Also Published As

Publication number Publication date
CH421973A (en) 1966-10-15
GB989456A (en) 1965-04-22
GB989455A (en) 1965-04-22
ES287587A1 (en) 1963-11-01
BR6348745D0 (en) 1973-07-03
FR1514917A (en) 1968-03-01
DK115916B (en) 1969-11-24

Similar Documents

Publication Publication Date Title
BE618998A (en) Synchronizing mechanism.
GB1002278A (en) Cytidine derivatives and the preparation thereof
DK108166C (en) Process for the preparation of alkali metal boranates, in particular sodium boranate, or alkali metal boranate-containing reaction mixtures.
CA625059A (en) Thermal exchange means between fluids, particularly flame or fume tubes
FR1434734A (en) Container, including tin can, with heat source
CA629879A (en) Heat exchangers
DK105462C (en) Process for the preparation of O-acetyl-3,5-dimethylbenzheparide or alkali metal salts thereof.
DK102858C (en) Process for the preparation of 3-oxo-17β-hydroxy-10β-allyl-Δ <4.9 (11)> -estradiene or its esters.
CA632845A (en) Tube for heat exchanger
AU279372B2 (en) Processing alkali metal vapor tubes
CA621013A (en) Heat transmitting tubes
CA624497A (en) Heating device for the melting of rods or tubes made of glass, or the like
AU2596063A (en) Means for heating and thermally homogenising the glass ina working chamber ofa glass furnace
CA609528A (en) Heat exchanger tube
CA617910A (en) Heat exchanger
CA614166A (en) Heat exchanger
AU247235B2 (en) Heat exchanger
AU247569B2 (en) Heat exchanger
AU257063B2 (en) Heat exchanger
CA630395A (en) Heat exchanger
CA630317A (en) Heat exchanger
CA613103A (en) Heat exchanger
CA623110A (en) Heat exchanger
CA627155A (en) Heat exchanger
DK98558C (en) Process for the preparation of 3α-phosphato-11-oxo-20,20-bis-hydroxymethyl-5β-pregnane or its alkali metal salts or inorganic or organic diesters.